Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | GSK2334470 | 1.0 | -0.8097 | -0.11511 |
| HCC1500 | GSK2334470 | 1.0 | -0.2401 | -0.11686 |
| HCC1500 | GSK2334470 | 3.16227766017 | -0.0181 | -0.15580 |
| HCC1500 | GSK2334470 | 3.16227766017 | -0.6375 | -0.15054 |
| HCC1500 | GSK2334470 | 3.16227766017 | -0.8756 | -0.02545 |
| HCC1500 | GSK2334470 | 10.0 | 0.0036 | -0.15150 |
| HCC1500 | GSK2334470 | 10.0 | -0.7194 | -0.18701 |
| HCC1500 | GSK2334470 | 10.0 | -0.4701 | -0.13446 |
| HCC1500 | Ribociclib | 0.001 | 0.8225 | -0.24023 |
| HCC1500 | Ribociclib | 0.001 | 0.7155 | -0.22856 |
| HCC1500 | Ribociclib | 0.001 | -0.1400 | -0.16670 |
| HCC1500 | Ribociclib | 0.00316227766017 | -0.2984 | -0.17162 |
| HCC1500 | Ribociclib | 0.00316227766017 | 1.0136 | -0.23318 |
| HCC1500 | Ribociclib | 0.00316227766017 | 0.6982 | -0.13261 |
| HCC1500 | Ribociclib | 0.01 | -0.5686 | -0.20506 |
| HCC1500 | Ribociclib | 0.01 | -0.0603 | -0.16862 |
| HCC1500 | Ribociclib | 0.01 | 2.4674 | -0.16837 |
| HCC1500 | Ribociclib | 0.0316227766017 | 0.2054 | -0.13644 |
| HCC1500 | Ribociclib | 0.0316227766017 | 0.0597 | -0.23205 |
| HCC1500 | Ribociclib | 0.0316227766017 | 1.8517 | -0.16158 |
| HCC1500 | Ribociclib | 0.1 | 0.7683 | -0.16786 |
| HCC1500 | Ribociclib | 0.1 | 0.4561 | -0.17980 |
| HCC1500 | Ribociclib | 0.1 | 0.0946 | -0.13410 |
| HCC1500 | Ribociclib | 0.316227766017 | -0.1590 | -0.12579 |
| HCC1500 | Ribociclib | 0.316227766017 | 0.7505 | -0.22255 |